Sfoglia per Autore
Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likely.
2004 MARTINELLI G; RONDONI M; BUONAMICI S; OTTAVIANI E; PICCALUGA PP; MALAGOLA M; BACCARANI M.
The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients.
2004 PICCALUGA PP; MALAGOLA M; AMABILE M; RONDONI M; PAOLINI S; PANE F; RUSSO D; VISANI G; BACCARANI M.; MARTINELLI G.
Soft tissue and skeletal involvement in FIP1L1-PDGFR-A positive chronic eosinophilic leukemia: imatinib mesylate may induce complete molecular and imaging remission
2004 MALAGOLA M; MARTINELLI G.; RONDONI M; OTTAVIANI E; PICCALUGA PP; RICCI P; VISANI G; BACCARANI M.
Anti-leukemic and anti-GVHD effects of campath-1H in acute lymphoblastic leukemia relapsed after stem-cell transplantation.
2004 PICCALUGA PP; MARTINELLI G; MALAGOLA M; RONDONI M; BIANCHINI M; VIGNA E; BOSI C; GAITANI S; VISANI G; BACCARANI M.
Detection of serine 473 phosphorylated Akt in acute myeloid leukaemia blasts by flow cytometry
2004 TAZZARI PL; CAPPELLINI A; GRAFONE T; MANTOVANI I; RICCI F; BILLI AM; OTTAVIANI E; CONTE R; MARTINELLI G.; MARTELLI AM.
Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome.
2004 MARTINELLI G; MALAGOLA M; OTTAVIANI E; ROSTI G; TRABACCHI E; BACCARANI M.
First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients.
2004 PICCALUGA PP; MARTINELLI G; RONDONI M; MALAGOLA M; GAITANI S; VISANI G; BACCARANI M.
No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: is intensity of therapy or high dose Ara-C crucial for response?
2004 VISANI G; ISIDORI A; GRAFONE T; TOSI P; SANTINI V; MALAGOLA M; MARTINELLI G.; PICCALUGA PP; GRAZIEV D; OTTAVIANI E; SPARAVENTI G; TURA S.
Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas
2004 PICCALUGA PP; MARTINELLI G.; RONDONI M; MALAGOLA M; GAITANI S; ISIDORI A; BONINI A; GUGLIOTTA L; LUPPI M; MORSELLI M; SPARAVENTI G; VISANI G; BACCARANI M.
Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells.
2004 TENEDINI E; FAGIOLI ME; VIANELLI N; TAZZARI PL; RICCI F; TAGLIAFICO E; RICCI P; GUGLIOTTA L; MARTINELLI G; TURA S; BACCARANI M.; FERRARI S; CATANI L.
Babesia infection in Italy
2004 PICCALUGA PP; POLETTI G; MARTINELLI G.; GHERLINZONI F
Denaturing-HPLC-based assay for detection of ABL mutations in Chronic Myeloid Leukemia patients resistant to Imatinib
2004 SOVERINI S; MARTINELLI G.; AMABILE M; POERIO A; BIANCHINI M; ROSTI G; PANE F; SAGLIO G; BACCARANI M.
Imatinib Mesylate Determines a High Frequency of Major Molecular Responses in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia on Behalf of the GIMEMA CML WP.
2005 Iacobucci, I; Testoni, N; Rosti, G; Amabile, M; Poerio, A; Soverini, S; Colarossi, S; Gnani, A; Ottaviani, E; Castagnetti, F; Terragna, C; Renzulli, M; Grafone, T; Cilloni, D; Pane, F; Saglio, G; Baccarani, M; Martinelli, G
Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia.
2005 PICCALUGA PP; MARTINELLI G; MALAGOLA M; RONDONI M; BONIFAZI F; BANDINI G; VISANI G; BACCARANI M.
Application of flow cytometry to molecular medicine: Detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts
2005 Cappellini A; Mantovani I; Tazzari PL; Grafone T; Martinelli G; Cocco L; Martelli AM
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway
2005 R. Bortul; P.L. Tazzari; A.M. Billi; G. Tabellini; I. Mantovani; A. Cappellini; T. Grafone; G. Martinelli; R. Conte; A.M. Martelli
Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target?
2005 Malagola M; Martinelli G; Rondoni M; Paolini S; Gaitani S; Arpinati M; Piccaluga PP; Amabile M; Basi C; Ottaviani E; Candoni A; Gottardi E; Cilloni D; Bocchia M; Saglio G; Lauria F; Fanin R; Visani G; Marre MC; Maderna M; Rancati F; Vinaccia V; Russo D; Baccarani M.
Impiego del pegfilgrastim in associazione cn R-CHOP in un paziente critico affetto da un linfoma non Hodgkin aggressivo primitivo del cuore.
2005 Vigna E; Placci A; Laterza C; Agostinelli C; Papayannidis C; Martinelli G; Pileri SA; Piccaluga PP.
Fattibilità ed efficacia del regime chemioterapico My-Flaig (mylotarg, fludarabina, citosina arabinsoide, idarubicina e pegfilgrastim) nella terapia della leucemia acuta mieloide.
2005 Piccaluga PP; Vigna E; Martinelli G.
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients
2005 Russo D; Malagola M; Vivo A; Fiacchini M; Martinelli G; Piccaluga PP; Damiani D; Candoni A; Michielutti A; Castelli M; Testoni N; Ottaviani E; Rondoni M; Pricolo G; Mazza P; Zuffa E; Zaccaria A; Raspadori D; Bocchia M; Lauria F; Bonini A; Avanzini P; Gugliotta L; Visani G; Fanin R; Baccarani M
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likely. | MARTINELLI G; RONDONI M; BUONAMICI S; OTTAVIANI E; PICCALUGA PP; MALAGOLA M; BACCARANI M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients. | PICCALUGA PP; MALAGOLA M; AMABILE M; RONDONI M; PAOLINI S; PANE F; RUSSO D; VISANI G; BACCARANI M....; MARTINELLI G. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
Soft tissue and skeletal involvement in FIP1L1-PDGFR-A positive chronic eosinophilic leukemia: imatinib mesylate may induce complete molecular and imaging remission | MALAGOLA M; MARTINELLI G.; RONDONI M; OTTAVIANI E; PICCALUGA PP; RICCI P; VISANI G; BACCARANI M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | ECR25.full.pdf |
Anti-leukemic and anti-GVHD effects of campath-1H in acute lymphoblastic leukemia relapsed after stem-cell transplantation. | PICCALUGA PP; MARTINELLI G; MALAGOLA M; RONDONI M; BIANCHINI M; VIGNA E; BOSI C; GAITANI S; VISAN...I G; BACCARANI M. | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
Detection of serine 473 phosphorylated Akt in acute myeloid leukaemia blasts by flow cytometry | TAZZARI PL; CAPPELLINI A; GRAFONE T; MANTOVANI I; RICCI F; BILLI AM; OTTAVIANI E; CONTE R; MARTIN...ELLI G.; MARTELLI AM. | 2004-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome. | MARTINELLI G; MALAGOLA M; OTTAVIANI E; ROSTI G; TRABACCHI E; BACCARANI M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients. | PICCALUGA PP; MARTINELLI G; RONDONI M; MALAGOLA M; GAITANI S; VISANI G; BACCARANI M. | 2004-01-01 | LEUKEMIA RESEARCH | - | 1.01 Articolo in rivista | - |
No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: is intensity of therapy or high dose Ara-C crucial for response? | VISANI G; ISIDORI A; GRAFONE T; TOSI P; SANTINI V; MALAGOLA M; MARTINELLI G.; PICCALUGA PP; GRAZI...EV D; OTTAVIANI E; SPARAVENTI G; TURA S. | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas | PICCALUGA PP; MARTINELLI G.; RONDONI M; MALAGOLA M; GAITANI S; ISIDORI A; BONINI A; GUGLIOTTA L; ...LUPPI M; MORSELLI M; SPARAVENTI G; VISANI G; BACCARANI M. | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells. | TENEDINI E; FAGIOLI ME; VIANELLI N; TAZZARI PL; RICCI F; TAGLIAFICO E; RICCI P; GUGLIOTTA L; MART...INELLI G; TURA S; BACCARANI M.; FERRARI S; CATANI L. | 2004-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
Babesia infection in Italy | PICCALUGA PP; POLETTI G; MARTINELLI G.; GHERLINZONI F | 2004-01-01 | THE LANCET INFECTIOUS DISEASES | - | 1.01 Articolo in rivista | - |
Denaturing-HPLC-based assay for detection of ABL mutations in Chronic Myeloid Leukemia patients resistant to Imatinib | SOVERINI S; MARTINELLI G.; AMABILE M; POERIO A; BIANCHINI M; ROSTI G; PANE F; SAGLIO G; BACCARANI M. | 2004-01-01 | CLINICAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
Imatinib Mesylate Determines a High Frequency of Major Molecular Responses in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia on Behalf of the GIMEMA CML WP. | Iacobucci, I; Testoni, N; Rosti, G; Amabile, M; Poerio, A; Soverini, S; Colarossi, S; Gnani, A; O...ttaviani, E; Castagnetti, F; Terragna, C; Renzulli, M; Grafone, T; Cilloni, D; Pane, F; Saglio, G; Baccarani, M; Martinelli, G | 2005-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia. | PICCALUGA PP; MARTINELLI G; MALAGOLA M; RONDONI M; BONIFAZI F; BANDINI G; VISANI G; BACCARANI M. | 2005-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
Application of flow cytometry to molecular medicine: Detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts | Cappellini A; Mantovani I; Tazzari PL; Grafone T; Martinelli G; Cocco L; Martelli AM | 2005-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | - | 1.01 Articolo in rivista | - |
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway | R. Bortul; P.L. Tazzari; A.M. Billi; G. Tabellini; I. Mantovani; A. Cappellini; T. Grafone; G. Ma...rtinelli; R. Conte; A.M. Martelli | 2005-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target? | Malagola M; Martinelli G; Rondoni M; Paolini S; Gaitani S; Arpinati M; Piccaluga PP; Amabile M; B...asi C; Ottaviani E; Candoni A; Gottardi E; Cilloni D; Bocchia M; Saglio G; Lauria F; Fanin R; Visani G; Marre MC; Maderna M; Rancati F; Vinaccia V; Russo D; Baccarani M. | 2005-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
Impiego del pegfilgrastim in associazione cn R-CHOP in un paziente critico affetto da un linfoma non Hodgkin aggressivo primitivo del cuore. | Vigna E; Placci A; Laterza C; Agostinelli C; Papayannidis C; Martinelli G; Pileri SA; Piccaluga PP. | 2005-01-01 | CONTINUING EDUCATION IN ONCOLOGIA | - | 1.01 Articolo in rivista | - |
Fattibilità ed efficacia del regime chemioterapico My-Flaig (mylotarg, fludarabina, citosina arabinsoide, idarubicina e pegfilgrastim) nella terapia della leucemia acuta mieloide. | Piccaluga PP; Vigna E; Martinelli G. | 2005-01-01 | CONTINUING EDUCATION IN ONCOLOGIA | - | 1.01 Articolo in rivista | - |
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients | Russo D; Malagola M; Vivo A; Fiacchini M; Martinelli G; Piccaluga PP; Damiani D; Candoni A; Michi...elutti A; Castelli M; Testoni N; Ottaviani E; Rondoni M; Pricolo G; Mazza P; Zuffa E; Zaccaria A; Raspadori D; Bocchia M; Lauria F; Bonini A; Avanzini P; Gugliotta L; Visani G; Fanin R; Baccarani M | 2005-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile